Related Experiment Video
Updated: Jan 14, 2026

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
Design and Implementation of a High-Throughput Experimentation Platform to Accelerate Drug Discovery
Amanda W Dombrowski1, Ana L Aguirre1, Ying Wang1
1AbbVie, Inc., North Chicago, Illinois 60064, United States.
AbbVie developed a high-throughput experimentation platform for medicinal chemistry. Analysis of five years of data revealed optimal reaction conditions for common chemical transformations.
Area of Science:
- Drug discovery
- Medicinal chemistry
- Chemical synthesis
Background:
- High-throughput experimentation (HTE) is crucial for accelerating drug discovery.
- Optimizing reaction conditions is essential for efficient medicinal chemistry workflows.
- AbbVie's Discovery Chemistry organization sought to enhance its HTE capabilities.
Purpose of the Study:
- To describe the development and function of a novel HTE platform.
- To outline strategies and approaches tailored for medicinal chemistry.
- To identify and report optimal reaction conditions for frequently used transformations.
Main Methods:
- Development of a specialized HTE platform.
- Data collection and analysis from five years of platform usage.
- Statistical analysis to determine top-performing reaction conditions.
Main Results:
- Successful implementation of the HTE platform within Discovery Chemistry.
- Identification of the most effective reaction conditions for key chemical transformations.
- A comprehensive dataset of optimized reactions for medicinal chemistry applications.
Conclusions:
- The developed HTE platform significantly enhances medicinal chemistry efficiency.
- The identified optimal reaction conditions provide valuable guidance for synthesis.
- This work facilitates faster and more effective drug discovery processes.
More Related Videos
08:58Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
Published on: October 17, 2025
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015